BARDA is supporting America’s Blood Centers in coordinating the collection and distribution of convalescent plasma for therapeutic use in treating COVID-19 hospitalized patients. Convalescent plasma has potential to be one of the first therapeutics in use on the front linesand is collected from patients who have recovered from COVID-19. It may contain antibodies against SARS-CoV-2 (the virus that causes COVID-19).
The use of convalescent plasma has been studied in outbreaks of other respiratory infections, including the 2009-2010 H1N1 influenza virus pandemic, 2003 SARS-CoV-1 epidemic, and the 2012 MERS-CoV epidemic. Although preliminary studies completed in China are promising, convalescent plasma has not been shown to be effective in every disease studied and additional studies are needed to show whether convalescent plasma is an effective treatment for COVID-19.
BARDA and America’s Blood Centers are working closely with the U.S. Food and Drug Administration (FDA) which is coordinating across the U.S. government on a unified effort to collect convalescent plasma for use as a treatment for COVID-19 patients and in clinical trials.
This award is one component of BARDA’s rapidly expanding COVID-19 medical countermeasure portfolio; visit BARDA’s COVID-19 Portfolio to learn more.
About America’s Blood Centers:
The following information is provided by the company and does not indicate endorsement by the federal government of the company or its products.
America’s Blood Centers provides representation and advocacy on behalf of its member blood centers, ensuring their voices are heard in the development of national health policy and before decision makers in federal agencies and the U.S. Congress. America’s Blood Centers also provides its members with scientific, medical, technical, quality, and regulatory expertise. America’s Blood Centers has been recognized by the U.S. Congress for our critical work in patient care and disaster preparedness and response.
To find a blood center to arrange a donation of convalescent plasma, visit https://americasblood.org/convalescentplasma/.